Clearside Biomedical Inc. (CLSD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM

Clearside Biomedical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-34.35M -32.48M -32.95M 376K
Depreciation & Amortization
226K 67K 145K 178K
Stock-Based Compensation
4.51M 4.2M 4.88M 5.05M
Other Working Capital
n/a 106K 122K -4.47M
Other Non-Cash Items
6.59M 9.36M 3.32M -998K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.68M 720K 11.24M -15.34M
Operating Cash Flow
-24.7M -18.14M -13.37M -10.73M
Capital Expenditures
-977K -1.78M -246K n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-16.91M n/a n/a n/a
Sales Maturities Of Investments
17.25M n/a n/a n/a
Other Investing Acitivies
-977K n/a -528K n/a
Investing Cash Flow
-638K -1.78M -246K n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
47K -1.25M 30.77M 499K
Financial Cash Flow
16.44M 414K 31.33M 23.78M
Net Cash Flow
-8.9M -19.5M 17.72M 13.05M
Free Cash Flow
-25.68M -19.91M -13.61M -10.73M